Transformational Opportunity on the Horizon Zevra Therapeutics (ZVRA) is set to join the prestigious Nasdaq Biotechnology Index (NBI) beginning December 23, 2024. This milestone marks
Author: Violet Slater
Violet Slater is a distinguished author and thought leader in the realms of new technologies and fintech. She holds a Master’s degree in Technology Management from the prestigious University of Southern California, where she developed a keen insight into the dynamic intersection of finance and innovation. Violet's career took shape at FinTech Solutions, where she honed her expertise in financial systems and digital transformation. Her experience there has provided her with a comprehensive understanding of the evolving landscape of financial technologies. Through her writing, Violet aims to demystify complex concepts and engage a wide audience, making her a sought-after voice in the industry.
Big Moves at MAIA Biotechnology! Insider Buying and Market Insights
Significant Share Purchase Revealed In a noteworthy development on December 13th, Stan Smith, a director at MAIA Biotechnology, Inc., made a substantial investment by acquiring